U.S. markets closed

Samsung Biologics Co.,Ltd. (207940.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
933,000.00+17,000.00 (+1.86%)
At close: 3:30PM KST
Full screen
Loading interactive chart...
  • PR Newswire

    Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative

    Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, announced the signing of an MOU today to participate in the Frontier 1.5D initiative to develop a climate risk management model as part of 2050 Carbon Neutral Strategy in response to the ongoing challenges associated with global climate change.

  • PR Newswire

    Samsung Biologics Reports Second Quarter 2021 Financial Results

    Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced strong financial results for the second quarter of fiscal 2021.

  • PR Newswire

    Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy

    Samsung Biologics (KRX: 207940.KS), one of the world's leading contract development and manufacturing organization (CDMO), signed a strategic partnership agreement with Kineta, Inc., a clinical-stage biotech company developing novel immunotherapies in oncology. Samsung Biologics will provide end-to-end CDMO service from cell line development, clinical drug substance, and drug product manufacturing services to support IND filing for KVA12.1, Kineta's novel anti-VISTA antibody in development for t